Information Provided By:
Fly News Breaks for February 26, 2019
BWXT
Feb 26, 2019 | 08:56 EDT
Maxim analyst Tate Sullivan raised his price target on BWX Technologies to $65 and kept his Buy rating after its Q4 earnings beat and forecast of growing EPS by low-double digits over the next 3-5 year period. The analyst adds that while the company's dividend increase was shy of his expectations, BWX Technologies' stock buyback of $152M in the period exceeded his forecast of $50M.
News For BWXT From the Last 2 Days
BWXT
Mar 28, 2024 | 07:15 EDT
BofA raised the firm's price target on BWX Technologies to $115 from $82 and keeps a Buy rating on the shares. BWX is "uniquely positioned to two major emerging secular themes," namely the submarine buildup in defense and the increasing role of nuclear power for green and secure energy, the analyst tells investors. In addition, EBITDA profitability and expansion into therapeutics makes BWXT Medical a "fundamentally more attractive business," the analyst contends.